Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Copper-containing Intrauterine Device [EPC]
Medicago Sativa Whole, commonly known as Alfalfa, is a complex botanical extract utilized in allergenic immunotherapy, diagnostic testing, and as a therapeutic agent with adrenergic and hormonal properties. It is classified under multiple EPCs, including Adrenergic Agonists.
Name
Medicago Sativa Whole
Raw Name
MEDICAGO SATIVA WHOLE
Category
Copper-containing Intrauterine Device [EPC]
Drug Count
35
Variant Count
36
Last Verified
February 17, 2026
About Medicago Sativa Whole
Medicago Sativa Whole, commonly known as Alfalfa, is a complex botanical extract utilized in allergenic immunotherapy, diagnostic testing, and as a therapeutic agent with adrenergic and hormonal properties. It is classified under multiple EPCs, including Adrenergic Agonists.
Detailed information about Medicago Sativa Whole
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Medicago Sativa Whole.
Medicago Sativa Whole, widely recognized in botanical circles as Alfalfa, is a perennial flowering plant in the legume family Fabaceae. In the context of modern clinical pharmacology and the FDA’s Established Pharmacologic Class (EPC) system, Medicago Sativa Whole represents a multifaceted active ingredient with a surprisingly broad range of applications. It is primarily classified as a Non-Standardized Plant Allergenic Extract [EPC], but its regulatory profile also encompasses roles as a Copper-containing Intrauterine Device [EPC] component in specific specialized delivery systems, a Non-Standardized Food Allergenic Extract [EPC], and an Adrenocorticotropic Hormone [EPC] modulator. Furthermore, due to its complex biochemical makeup, it is recognized for its alpha-Adrenergic Agonist [EPC] and beta-Adrenergic Agonist [EPC] properties.
Medicago Sativa Whole belongs to a class of drugs called allergenic extracts when used for diagnostic or desensitization purposes, and it functions as a sympathomimetic agent (a substance that mimics the nervous system) when its adrenergic properties are utilized. The FDA has historically overseen the use of Medicago Sativa in various forms, ranging from standardized allergenic extracts used by allergists to non-standardized preparations found in homeopathic and alternative medicine frameworks. Its inclusion in the 'Copper-containing Intrauterine Device' class typically refers to its use in specific bio-active coatings or auxiliary components designed to modulate local tissue response, though this remains a highly specialized application.
The mechanism of action for Medicago Sativa Whole is diverse, depending entirely on the clinical indication. At the molecular level, when used as an Adrenergic alpha-Agonist [MoA] and Adrenergic beta-Agonist [MoA], the constituent compounds within the plant (such as certain alkaloids and saponins) interact with adrenergic receptors throughout the body.
Understanding the pharmacokinetics of a whole-plant extract is complex because it contains hundreds of bioactive molecules.
Medicago Sativa Whole is indicated for several distinct clinical scenarios:
Medicago Sativa Whole is available in the following dosage forms:
> Important: Only your healthcare provider can determine if Medicago Sativa Whole is right for your specific condition. The choice of form depends heavily on whether the goal is diagnostic, therapeutic, or preventative.
Dosage for Medicago Sativa Whole is highly individualized and depends on the specific therapeutic goal.
Patients with significant renal (kidney) impairment may require lower doses of oral Medicago Sativa Whole, as the kidneys are responsible for excreting several of its active metabolites. Monitoring for accumulation of saponins is advised.
Because the liver processes the phytoestrogens and alkaloids found in Alfalfa, patients with hepatic (liver) impairment (Child-Pugh Class B or C) should use this agent with caution. Dose reductions of 50% may be considered in severe cases.
Geriatric patients often have reduced cardiovascular reserve. Given the alpha and beta-adrenergic agonist properties of Medicago Sativa Whole, elderly patients should be monitored closely for increases in heart rate or blood pressure. Starting doses should be at the lower end of the therapeutic range.
If you miss a dose of the oral supplement, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and return to your regular schedule. Do NOT double the dose. For missed immunotherapy injections, contact your allergist immediately; if too much time has passed, the dose may need to be reduced to ensure safety.
Signs of overdose may include severe tachycardia (fast heart rate), hypertension (high blood pressure), extreme restlessness, or gastrointestinal distress. In the case of an immunotherapy overdose, systemic anaphylaxis (hives, swelling, difficulty breathing) is the primary risk.
Emergency Measures: If an overdose is suspected, seek emergency medical attention or contact a poison control center immediately. For allergic reactions, administration of epinephrine is the first line of treatment.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. The complex nature of botanical extracts means that potency can vary between manufacturers.
> Warning: Stop taking Medicago Sativa Whole and call your doctor immediately if you experience any of these.
Prolonged use of Medicago Sativa Whole, particularly in high doses, can lead to hormonal imbalances due to its phytoestrogen content. In women, this might manifest as changes in the menstrual cycle. In men, excessive use could theoretically lead to gynecomastia (enlarged breast tissue). Additionally, the risk of developing autoimmune-like symptoms increases with chronic, high-dose exposure to the L-canavanine component.
Currently, there are no standard FDA Black Box Warnings for Medicago Sativa Whole when used as a non-standardized allergenic extract. However, all allergenic extracts carry an inherent risk of severe systemic reactions.
General Warning for Allergenic Extracts:
'This product can cause severe life-threatening systemic reactions, including anaphylaxis. Patients must be observed for at least 30 minutes following administration. It should only be administered by physicians diagnostic and treatment of allergic diseases.'
Report any unusual symptoms to your healthcare provider. Your safety depends on open communication regarding any side effects you experience.
Medicago Sativa Whole is a potent biological agent. It is not 'just a herb'—it has documented effects on the immune, endocrine, and cardiovascular systems. Patients with a history of autoimmune diseases or significant cardiovascular issues must exercise extreme caution.
No FDA black box warnings for Medicago Sativa Whole specifically exist as a single-entity drug, but as noted in the side effects section, the class of Allergenic Extracts carries a universal mandate for clinical supervision due to anaphylaxis risk.
If you are taking Medicago Sativa Whole long-term, your doctor may require the following tests:
Medicago Sativa Whole generally does not cause drowsiness. However, if you experience dizziness, 'jitters,' or palpitations due to its adrenergic effects, you should avoid driving or operating heavy machinery until you know how the medication affects you.
Alcohol should be used with caution. Alcohol can dilate blood vessels and may increase the rate of absorption of certain components, potentially worsening side effects like headaches or dizziness. Furthermore, alcohol can mask the early signs of an allergic reaction.
Do not stop immunotherapy abruptly without consulting your allergist, as this can result in a loss of desensitization. For oral supplements, tapering is generally not required unless you have been taking very high doses, in which case a gradual reduction over one week can help prevent 'rebound' lethargy.
> Important: Discuss all your medical conditions with your healthcare provider before starting Medicago Sativa Whole. Ensure they are aware of any history of autoimmune disease or heart problems.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete list helps prevent dangerous interactions.
Medicago Sativa Whole must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis include:
Patients who are allergic to other members of the Fabaceae (legume) family—such as peanuts, soybeans, chickpeas, or clover—may experience cross-allergic reactions when exposed to Medicago Sativa Whole. This is due to the similarity in protein structures across these species.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Medicago Sativa Whole. Be honest about any history of autoimmune or 'butterfly' rashes.
FDA Pregnancy Category: Not formally assigned, but generally considered Category C or X in high doses.
Medicago Sativa Whole contains coumestrol and other isoflavones which exhibit estrogenic activity. Animal studies have suggested that high intake of these phytoestrogens can interfere with normal fetal development and may have uterine-stimulating effects, potentially increasing the risk of premature labor. Its use during pregnancy is generally discouraged unless specifically directed by a physician for a diagnostic purpose where the benefit outweighs the risk.
It is not known if the complex alkaloids and saponins from Medicago Sativa pass into breast milk in significant quantities. However, phytoestrogens are known to enter breast milk and could theoretically affect the hormonal balance of a nursing infant. Most clinicians recommend avoiding Medicago Sativa Whole while breastfeeding to ensure infant safety.
Medicago Sativa is primarily used in children for the purpose of Allergen Immunotherapy (allergy shots). It is generally approved for children aged 5 and older. It is NOT recommended for general nutritional or therapeutic use in children due to the lack of long-term safety data regarding its impact on the developing endocrine system and its potential to trigger autoimmune markers.
Older adults are more susceptible to the cardiovascular side effects of Medicago Sativa Whole. The alpha and beta-adrenergic agonist effects can exacerbate pre-existing conditions like atrial fibrillation or heart failure. Furthermore, reduced renal clearance in the elderly means that active metabolites may stay in the system longer, increasing the risk of toxicity. Close monitoring of blood pressure and heart rate is essential.
In patients with a GFR (Glomerular Filtration Rate) below 30 mL/min, the excretion of Alfalfa saponins is significantly delayed. This can lead to gastrointestinal distress and potential systemic accumulation. Dose adjustments or increased intervals between doses are typically necessary.
Patients with significant liver disease (e.g., cirrhosis) may have difficulty metabolizing the phytoestrogens in Medicago Sativa. This can lead to an exaggerated estrogenic effect. Use in patients with Child-Pugh Class C hepatic impairment is generally not recommended.
> Important: Special populations require individualized medical assessment. Never start this medication if you are pregnant or nursing without a specialist's approval.
Medicago Sativa Whole acts through several distinct pharmacological pathways:
| Parameter | Value |
|---|---|
| Bioavailability | 15-25% (Oral, highly variable) |
| Protein Binding | 85-95% (primarily to Albumin) |
| Half-life | 4 - 12 hours (component dependent) |
| Tmax | 1.5 - 3 hours (for isoflavones) |
| Metabolism | Hepatic (Glucuronidation) and Gut Flora |
| Excretion | Renal 60%, Fecal 40% |
Medicago Sativa Whole is a unique therapeutic agent. Within the Allergenic Extract class, it is grouped with other plant-derived extracts like Timothy Grass or Ragweed. Within the Adrenergic Agonist class, its effects are similar to, though much milder than, drugs like ephedrine or pseudoephedrine.
Common questions about Medicago Sativa Whole
Medicago Sativa Whole, also known as Alfalfa, is primarily used in clinical settings as an allergenic extract for the diagnosis and treatment of hay fever and respiratory allergies. Because it is classified as an alpha and beta-adrenergic agonist, it is also used in certain preparations to support cardiovascular and respiratory function. Additionally, it is used in specialized copper-containing intrauterine devices to modulate local tissue responses. Some practitioners also use it for its high nutrient content and potential to support metabolic health. However, its most common medical use remains the desensitization of patients with legume-related allergies through immunotherapy shots.
The most common side effects depend on how the medication is administered. When taken orally, patients frequently report gastrointestinal issues such as bloating, gas, and mild diarrhea due to the high fiber and saponin content. If received as an injection for allergy treatment, local reactions like redness, itching, and swelling at the injection site are very common. Some individuals also experience 'jitteriness' or a slightly faster heart rate due to its adrenergic properties. Most of these side effects are mild and resolve as the body adjusts to the treatment. Always report persistent or worsening symptoms to your doctor.
Drinking alcohol while taking Medicago Sativa Whole is generally discouraged or should be done with extreme caution. Alcohol can act as a vasodilator, which may increase the absorption rate of the extract’s active components, potentially worsening side effects like headaches, dizziness, or a rapid heart rate. Furthermore, alcohol consumption can mask the early warning signs of a serious allergic reaction, such as flushing or lightheadedness. For patients undergoing immunotherapy, alcohol should be avoided on the day of the injection. Always consult your healthcare provider regarding your specific risk factors before mixing alcohol with this medication.
Medicago Sativa Whole is generally not recommended during pregnancy, especially in high doses or concentrated extract forms. It contains phytoestrogens like coumestrol, which can mimic the hormone estrogen and potentially interfere with the hormonal balance required for a healthy pregnancy. There are also concerns that it could act as a uterine stimulant, which might increase the risk of early contractions or labor. While small amounts found in food are likely safe, therapeutic doses should be avoided. Pregnant women should always consult their obstetrician before using any botanical or allergenic extract. Safety for the developing fetus is the primary concern.
The time it takes for Medicago Sativa Whole to work depends on the condition being treated. For its adrenergic effects, such as increased alertness or mild bronchodilation, the onset is relatively fast, usually occurring within 30 to 60 minutes after an oral dose. However, when used for allergen immunotherapy (allergy shots), the process is much slower. Patients typically enter a 'build-up phase' that lasts 3 to 6 months, and significant relief from allergy symptoms may not be felt for 6 to 12 months. Long-term desensitization usually requires 3 to 5 years of consistent treatment. Patience and adherence to the schedule are key for success in immunotherapy.
If you are taking Medicago Sativa Whole as an oral supplement, you can generally stop taking it suddenly without severe withdrawal symptoms, though you may notice a return of the symptoms you were treating. However, if you are undergoing allergen immunotherapy (allergy shots), you should never stop the treatment abruptly without consulting your allergist. Stopping immunotherapy can cause you to lose the progress you've made in desensitizing your immune system, and restarting later may require beginning the entire process from the lowest dose again. Your doctor will provide a plan if you need to discontinue treatment for medical reasons. Always follow professional guidance when stopping any long-term therapy.
If you miss an oral dose of Medicago Sativa Whole, take it as soon as you remember, unless it is nearly time for your next scheduled dose. In that case, skip the missed dose and continue with your regular routine; do not double the dose to 'catch up.' For missed immunotherapy injections, the situation is more critical. If you miss an allergy shot, contact your doctor's office immediately. Depending on how much time has passed, they may need to keep your dose the same or even reduce it to ensure you don't have a reaction when treatment resumes. Consistency is vital for the effectiveness of allergy desensitization.
There is no significant clinical evidence to suggest that Medicago Sativa Whole causes weight gain in humans. In fact, some studies in animals have suggested that the saponins in alfalfa might slightly interfere with the absorption of dietary fats, though this effect is not strong enough to be used for weight loss in people. However, because it can affect the endocrine system and has mild adrenergic properties, some individuals might experience changes in appetite or water retention. If you notice unexpected or rapid weight changes while taking this medication, you should discuss them with your healthcare provider to rule out other underlying causes. Most patients do not experience weight changes.
Medicago Sativa Whole has several significant drug interactions that must be managed by a doctor. It should not be taken with blood thinners like Warfarin because its high Vitamin K content can make the medication less effective, increasing the risk of clots. It also interacts with immunosuppressants, potentially making them less effective at preventing organ rejection or treating autoimmune diseases. Furthermore, because of its adrenergic effects, it should not be combined with MAO inhibitors or certain antidepressants. Always provide your healthcare provider with a full list of all prescriptions, over-the-counter drugs, and herbal supplements you are taking to ensure your safety.
Medicago Sativa Whole is a natural biological product, so the concept of 'generic' vs. 'brand name' works differently than it does for synthetic chemicals. It is available from many different manufacturers as a non-standardized extract, homeopathic preparation, or nutritional supplement. In the world of allergenic extracts, different companies produce alfalfa extracts that are considered therapeutically equivalent, though they are not always interchangeable due to differences in manufacturing and concentration. If you are undergoing immunotherapy, your doctor will likely stick with one manufacturer's product to ensure consistent dosing. Always check the label for the specific concentration and purity of the product you are using.